Urgent Alert for ICON Shareholders: Important Deadline Approaching in Class Action Lawsuit – Former Louisiana Attorney General Kahn Swick & Foti, LLC Urges Investors with Significant Losses to Act Now

Important Information for ICON plc Investors: Securities Class Action Lawsuit Filed

On April 1, 2025, Kahn Swick & Foti, LLC (“KSF”) and its partner, former Attorney General of Louisiana, Charles C. Foti, Jr., announced that they are filing a securities class action lawsuit against ICON plc (“ICON” or the “Company”) (NasdaqGS: ICLR) on behalf of investors who purchased the Company’s shares between July 27, 2023, and October 23, 2024, inclusive (the “Class Period”). The lawsuit is pending in the United States District Court for the Eastern District of New York.

Background

ICON is a global provider of technology-enabled clinical research services. The Company’s services include outsourced development and commercialization of drugs, biologics, and medical devices. ICON’s business model is designed to provide a comprehensive range of services to its clients, from early development through to commercialization.

The Allegations

The complaint alleges that ICON and certain of its executives made false and misleading statements and failed to disclose material information during the Class Period. Specifically, the complaint alleges that the Company downplayed the impact of certain regulatory issues on its business and failed to disclose that it was experiencing significant delays and cost overruns on certain projects. These issues allegedly caused the Company’s financial results to be materially misstated.

Impact on Individual Investors

If you purchased ICON shares during the Class Period and suffered losses as a result, you may be eligible to recover your damages by serving as a lead plaintiff in this action. As a lead plaintiff, you will be a representative party for all other class members in the action. The lead plaintiff will work with the attorneys to shape the litigation and help define the issues for the court. The lead plaintiff will also be entitled to a share of any recovery.

Impact on the World

The securities class action lawsuit against ICON has important implications for investors in the biotech and pharmaceutical industries. The allegations against ICON highlight the risks associated with investing in companies that rely on regulatory approvals for their products and services. The lawsuit also underscores the importance of accurate and transparent disclosures by public companies.

Conclusion

If you purchased ICON shares between July 27, 2023, and October 23, 2024, and suffered losses as a result, you may be eligible to recover your damages by serving as a lead plaintiff in this securities class action lawsuit. The lawsuit alleges that ICON and certain of its executives made false and misleading statements and failed to disclose material information during the Class Period. The case is pending in the United States District Court for the Eastern District of New York. For more information, or if you have any questions, please contact KSF at 1-877-515-1850 or [email protected].

  • ICON plc
  • Securities Class Action Lawsuit
  • Kahn Swick & Foti, LLC
  • Charles C. Foti, Jr.
  • July 27, 2023 – October 23, 2024
  • United States District Court for the Eastern District of New York

Leave a Reply